Literature DB >> 18568403

Cerulenin inhibits de novo sophorolipid synthesis of Candida bombicola.

I N A Van Bogaert1, D Develter, W Soetaert, E J Vandamme.   

Abstract

Synthesis of medium-chain sophorolipids by Candida bombicola is a challenging objective. One of the difficulties is that the obtained sophorolipids always represent a mixture of medium-chain and native de novo formed or long-chain sophorolipids. The fatty acid moiety of de novo sophorolipids is derived from the de novo synthesis of fatty acids. Fatty acid synthesis can be blocked by the antifungal agent cerulenin, an inhibitor if the fatty acid synthase (FAS) complex acting on the beta-ketoacyl thioester synthetase reaction. The toxic effect of cerulenin on C. bombicola was evaluated and 20 mg/ml was added in the stationary growth phase. No de novo formed sophorolipids were observed when the cells were cultured on merely glucose. Also when the hydrophilic substrate, 1,12-dodedanediol, was added, no de novo formed sophorolipids were detected, leading to a reduced complexity of the sophorolipid mixture.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18568403     DOI: 10.1007/s10529-008-9764-8

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  3 in total

1.  Redirecting the lipid metabolism of the yeast Starmerella bombicola from glycolipid to fatty acid production.

Authors:  Sylwia Jezierska; Silke Claus; Rodrigo Ledesma-Amaro; Inge Van Bogaert
Journal:  J Ind Microbiol Biotechnol       Date:  2019-09-11       Impact factor: 3.346

2.  Overview on Glycosylated Lipids Produced by Bacteria and Fungi: Rhamno-, Sophoro-, Mannosylerythritol and Cellobiose Lipids.

Authors:  Susanne Zibek; Gloria Soberón-Chávez
Journal:  Adv Biochem Eng Biotechnol       Date:  2022       Impact factor: 2.635

3.  NADPH accumulation is responsible for apoptosis in breast cancer cells induced by fatty acid synthase inhibition.

Authors:  Yanfen Cui; Pan Xing; Yuanyuan Wang; Miao Liu; Li Qiu; Guoguang Ying; Binghui Li
Journal:  Oncotarget       Date:  2017-05-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.